Electron beam computed tomography for the diagnosis of cardiac disease by Arad, Yadon
REFERENCES
1. Preble E. Impact of HIV/AIDS on African children. Sac Sci Med 1990; 31: 671 4
680.
2. Adjortolo-Johnson G, De Kock K, Ekpini E, et al. Prospective comparison of
mother-ta-child transmission of HIV-l and HIV-2 in Abidjan, Ivory Coast. JAMA
1994; 272: 462-466.
3. Marurn LH, Bagenda 0, Guay L, et al. Three-year mortality in a cohort of HIV-l
infected and uninfected Ugandan children. Abstract, 11 th International
Conference on AIDS, Vancouver, 1996.
4. Vetter KM, Djomand G, Zadi F, et al. Clinical spectrum of human
immunodeficiency virus disease in children in a West African city. Pediatr Infect
Dis J 1996; 15: 438-442.
5. NicoH A, Timaeus I, Kigadye AM, Walraven G. Killewo J. The impact of HIV-l
infection on mortality in children under 5 years of age in sub-Saharan Africa: a
demographic and epidemiologic analysis. AIDS 1994; 8: 995-1005.
6. Walraven G, Nicoll A, Njau M, Timaeus l. The impact of HIV-1 infection on child
health in sub-Saharan Africa: the burden on the health services. Trap Med Int
Health 1996; 1: 3-14.
7. Department of Health. Sixth national HIV survey of women attending antenatal
clinics of the public health services in the Republic of South Africa, October
1996. Epidemiological Comments 1996; 23: 3-17.
8. Friedland IR, Mclntyre JA. AIDS - the Baragwanath experience. S Afr Med J
1992; 82: 90-94.
9. Bhobat RA, Coovadia HM, Windsor IM. Some early observations on HIV infection
in children at King Edward VIII Hospital, Durban. S Afr Med J 1990; 78: 524-527.
10. Centers for Disease Control and Prevention. 1994 revised classification system
for human immunodeficiency virus infection in children less than 13 years of age.
MMWR 1994; 43: 1-19.
11. Topley JM. HIV infection in Zimbabwe. Arch Dis Child 1988; 63: 842-844.
12. Rodgers MF, Thomas PA, Starcher ET, Noa MC, Bush TJ, JaHe HW. Acquired
immunodeficiency syndrome in children: report of the Centers for Disease Control
national surveillance, 1982 to 1985. Pediatrics 1987; 79: 1008-1014.
13. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinataJly
acquired human immunodeficiency virus type 1 infection. N £ngl J Med 1989;
321: 1791-1796.
14. Tovo PA, De Martino M, Gabiano C, et al. Prognostic factors and survival in
children with perinatal HIV-1 infection. Lancet 1992; 339: 1249-1253.
15. Turner SJ, Denison M, Eppes se, Houchens R, Fanning T, Markson LE. Survivai
experience of 789 children with the acquired immunodeficiency syndrome.
Pediatr Infect Dis J 1993; 12: 310·320.
16. The European Collaborative Study. Natural history of vertically acquired human
immunodeficiency virus-1 infection. Pediatrics 1994; 94: 815-819.
17. Barnhart HX, CaldwelJ MS, Thomas P, et al. Natural history of human
immunodeficiency virus disease in perinatally infected children: an analysis from
the pediatric spectrum of disease project. Pediatrics 1996; 97: 710-716.
18. Morris CA, Araba-Owoyele L. Spector S, Maldonando YA. Disease patterns and
survival after acquired immunedeficiency syndrome diagnosis in human
immunodeficiency virus-infected children. Pediatr Infect Dis J 1996; 15: 321-328.
19. Njenga S, Nagelkerke N, Plummer F, Datta P, Ndinya-Achola J, Embree J. Natural
history of HIV-1 infected children in Nairobi, Kenya. Abstract, 11 th International
Conference on AIDS, Vancouver, 1996.
20. Jeena PM, Coovadia HM, Bhagwanjee S. Prospective, controlled study of the
outcome of human immunodeficiency virus-1 antibody positive children admitted
to an intensive care unit. Crit Care Med 1996; 24: 963-967.





This well established, comprehen-
sive guide sets out step by step
how patients with spinal cord injury
should be managed - moving
them from the scene of the
accident, through initial stabili-
sation, to special aftercare.
"A comprehensive, well illustrated
and indexed book, which is a vade mecum."
Paraplegia
ISBN 0 7279 1049 3 80 pages 1996
R154 (MASA members R146)







Electron beam computed tomography (EBCT) of the heart
is a new modality which will alter the way cardiology is
practised. It allows for the detection of early coronary
artery disease (CAD) in asymptomatic individuals,
regardless of their level of risk as assessed by traditional
risk factor analysis. Compared with risk analysis based on
risk factors alone, an assessment which also utilises
quantitative measurements of coronary artery plaque by
EBCT allows for more precise determination of the need
for medical therapy. Non-invasive intravenous contrast
EBCT coronary angiography can identify significant
obstructive CAD, and should reduce the need for
conventional coronary angiography. Incorporation of EBCT
into routine medical practice is more cost-effective than
other modalities currently available.
This paper reviews relevant original articles on EBCT
and preventive cardiology published in peer-reviewed
medical journals, and assesses the implications of EBCT
for preventive cardiology.
S Atr Med J 1998; 88; 558-563.
Limitations of traditional
evaluation of coronary heart
disease
Coronary artery disease (CAD) is the leading cause of death
in developed countries. Despite marked progress in the
diagnosis and treatment of CAD, its detection is limited by
the high incidence of silent, preclinical disease. In up to 50%
of patients the first symptom of atherosclerotic
cardiovascular disease is either an acute myocardial
infarction (MI) or sudden death.' Furthermore, although
subjects with a higher degree of obstruction may
subsequently be more likely to suffer a cardiac event,
angiography shows that half of those with a first or a fatal MI
have less than 50% coronary obstruction. This apparent
paradox is due to the much larger number of potential
patients with less extensive disease. The correlation
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Electron beam (ultrafast) CT (EBCT) is a relatively recent
technology which provides the needed tools for non-invasive
screening and quantification of coronary disease. The
efficacy of EBCT is due to the speed of data acquisition. In
contrast to conventional and helical CT which use a
mechanically moving cathode-ray tube, EBCT utilises an
electron gun which shoots an electron beam toward a series
of four semicircular tungsten rings. The beam is focused and
swung around the tungsten rings using a magnet. Since no
mechanical movement is required during the acquisition of a
single slice, the process is extremely quick. Thus only 50 -
100 milliseconds are required per image, allOWing for precise
ECG triggering and synchronisation, and resulting in a
freeze-motion image of the beating heart. The most
commonly used protocol generates 40 3 mm slices during a
single breath-hold, minimising breath artefacts. Using newer
software it is possible to obtain as many as 120 images per
run, allowing for thinner slices, more overlap between slices,
and a wider scan window (top to bottom). For routine
screening, actual scanning time is less than a minute and
the complete procedure can be done in 5 - 10 minutes.
Coronary EBCT is most commonly used to screen for
unsuspected CAD by measuring calcium deposition in the
walls of coronary arteries. The quantity of coronary artery
calcium in postmortem specimens, measured by chemical
or histological assays, is a marker for the presence of
atherosclerotic plaque and correlates with plaque volume, as
documented in autopsy studies (six studies, 2 500 hearts),
with correlation coefficients ranging from 0.75 to 0.94.17'22
EBCT-derived coronary artery calcium (CAG) scores
accurately measure coronary calcium mass"" and plaque
mass as documented by autopsy!4 In addition, EBCT-
determined CAC scores correlate with the extent of coronary
obstruction documented by coronary angiography in
symptomatic subjects. A recent report performed a Receiver
Operating Characteristic (ROC) analysis for the ability of
EBCT-derived CAC scores to predict coronary disease in
men and women undergoing angiography. It found an area
under the curve of 0.92 for the prediction of any disease and
0.83 and 0.88 for the prediction of 50% or greater stenosis
in women and men, respectively!S Budoff et a/. 26 studied 710
patients undergoing angiography and found a sensitivity to
detect obstructive CAD of 95% and an area under the ROC
curve of 0.82. Specificity was only 44%, but they used the
presence of any calcium as a cut-off point, which is
probably too inclusive. Most studies comparing coronary




11),13 suggest that risk-stratification based on non-invasive
anatomical definiton of carotid artery atherosclerosis can be
helpful in identifying subjects likely to benefit from therapy,
and may allow for relatively easy and inexpensive sequential
tracking of CAD over time. Because of the limited correlation
of coronary and carotid disease,""· however, direct, non-
invasive quantification of coronary disease would be




















between the pathological and angiographic estimates of the
extent of CAD is also adversely affected by the variance of
the baseline (pre-disease) vessel size, vascular remodelling
and underestimation of disease in reference vessels2 (Fig. 1).
Fig. 1. The effect of vascular remodelling on angiographic
analysis. The ability of vessels to dilate in response to ischaemia
downstream allows for retention of near-normal lumen size
despite progressive plaque build-up. This process not only
affects the assessment of disease in the culprit artery, but may
also affect the assessment of stenosis in the reference vessel,
resulting in a gross underestimation of the degree of stenosis.
(Adopted with permission from the American Heart Association.')
Approaches to detection of CAD based on cholesterol
concentrations are hampered by extensive overlap in the
distribution of total cholesterol between those destined to
develop symptomatic coronary heart disease and those who
remain disease-free.3 In fact, the majority of patients with
coronary disease have normal, or only mildly elevated,
cholesterol levels.. Measurements of cholesterol
concentration, the ratio of total cholesterol to high-density
lipoprotein (HDL) cholesterols.• or apolipoprotein
concentrations"· only slightly improve the discriminative
value. Other recently identified risk factors, such as
homocysteine, lipoprotein A and fibrinogen, have not been
shown to improve our discriminating powers SUbstantially.
Stress testing is also of limited usefulness in apparently
healthy middle-aged subjects, since the majority of positive
stress tests in such populations are falsely positive, and a
negative test result (Le. no evidence of ischaemia) adds just
one percentage point to prognostic power (from a pre-test
probability of remaining event-free of 0.96 to a post-test
probability of 0.97).9.10 For this reason, a recent statement
from the combined task force of the American College of
Cardiology and the American Heart Association has
concluded that there are no indications for the use of stress
testing in asymptomatic people (class I) and that such
routine screening may in fact be harmful (class Ill). The task
force has concluded that efficacy of stress testing is
debatable even for people with multiple CAD risk factors
(class liB)." Newer forms of stress testing, utilising either
radionuclide imaging or echocardiography, are expensive
and time-consuming and therefore ill-suited for use as
screening tests for CAD.
Recent studies, such as the Asymptomatic Carotid Artery
Progression StUdy (ACAPS)t2 and Pravastatin Limitation of
Atherosclerosis in the Coronary Arteries investigation (PLAC
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RECEIVER OPERATING CHARACTERISTIC CURVE
1-SP.ECIFICITY (FALSE-POSITIVE RATE)
Fig. 3. The ROC curve for prediction of future cardiovascular
events in asymptomatic subjects. For an average of 19 months
1 173 people with no history or symptoms of CVD were screened
and followed up. Eighteen subjects had 26 events (1 cardiac
death, 7 non-fatal Mls, 1 spontaneous thrombo-embolic stroke, 8
coronary artery bypass procedures and 9 coronary angioplasties).
Indications for all angioplasties and bypass surgery operations
were deemed justified by onset of new symptoms and/or new
positive stress tests, and all stress tests were done because of
new symptoms. The ROC analysis counts each patient only once.
A perfect test would have an area under the curve (AUC) of one.
The curve for the NCEP 11 guidelines (triangles) is based on
analysis of the 12-year follow-up data from the Lipid Research
Clinic Prevalence and Follow-up Studies.' (Reproduced with

























compared with 0.71 for either TST or ECG stress testing,.
and 0.77 for TST and ECG stress testing combined. This
finding was confirmed by Spadaro et al. 36 showing overall
accuracy of 0.79 for EBCT versus 0.63 for TST for the
prediction of angiographically documented coronary artery
disease.
More importantly, EBCT-derived calcium scores predict
future cardiovascular disease events. The only full follow-up
report on asymptomatic subjects evaluated the predictive
value of CAC scores in 1 173 subjects with no known CVD,
as well as a negative Rose Angina Questionnaire on
presentation. During an average follow-up of 19 months
(range 14 - 23 months), EBCT-derived CAC scores above
160 denoted an odds ratio for future events of 35.37 ROC
analysis for the ability of EBCT to predict cardiovascular
events showed an area under the ROC curve of 0.91 (Fig. 3).
symptomatic people have found sensitivities and
specificities of 74 - 86% and areas under the ROC curves of
0.8 - 0.9. This relationship holds for asymptomatic patients
as well. In a study of 36 asymptomatic subjects, Guerci et
al. 27 reported a correlation of 0.85 between coronary artery
calcium scores and the worst stenosis in any major coronary
artery segment, as determined by computer-assisted
quantitative coronary angiography at a blinded remote site.
The utility of CAC as a marker for the quantity of
atherosclerosis and the extent of coronary obstruction is
therefore well established. Specific risk analysis can be used
to identify optimal CAC scores (maximal accuracy) for a
desired degree of stenosis!' Further details as to the risk of
segment-specific significant CAD may be gained by
analysing the character of the calcific deposit. Thus Kajinami
et al."'" defined lesions as 'spotty,' 'long,' 'diffuse' or 'wide'.
The positive predictive values for significant stenosis and all
atherosclerotic lesions increased progressively from 0.04
and 0.17 for no calcification to 0.18 and 0.59 for spotty
calcifications, 0.32 and 0.87 for long lesions, 0040 and 0.84
for wide lesions and 0.56 and 0.96 for diffuse lesions."'"
Consistent with the limitation of angiography described
above, recent studies using intravascular ultrasound have
confirmed that occult coronary disease is often present in
sites of angiographically 'normal' coronary arteries,3D and
that coronary calcium, quantified with intravascular
ultrasonography (IVUS). is predictive of the total plaque
burden, although not of site-specific plaque volume." In
fact, EBCT can identify IVUS-confirmed CAD in
angiographically normal vessels32 (Fig. 2). It is therefore not
surprising that coronary EBCT can differentiate patients with
very early coronary artery wall irregularities from those with
perfectly smooth walls,33 and that even in subjects with
normal coronary angiography, the presence of coronary
calcification still imposes a threefold higher risk of a
subsequent cardiovascular event.""
Fig. 2. Comparison of coronary angiography, intravascular
sonography and EBCT-determined calcium deposition. Shown are
two segments of a coronary artery laden with plaque. One
segment (distally) is normal by all three methods. The proximal
segment shows a plaque by sonography and EBCT but is normal
by angiography. (Reproduced with permission from the American
College of Cardiology.")
EBCT-derived CAC scores compare favourably with
thallium stress testing (TST) for the preoiction of obstructive
disease in symptomatic subjects. Kajina,mi et al. 35 studied
251 subjects with suspected coronary disease with EBCT,
TST and angiography. They showed an overall accuracy for
predicting obstructive CAD of 0.85 for EBCT-derived CAC,
Furthermore, while the overall risk for a future CVD event
in this asymptomatic population was 1.5%, those with
scores above 160 had a 5% event rate and those with
scores above 680 had a 14% event rate. The conclusion
that EBCT is the best screening method for preclinical CAD
is supported by five other preliminary reports on
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Relationship of number of risk factors
and CAC to obstructive CAD
Fig. 4. Incremental predictive value of coronary calcium scores
for coronary obstruction. The likelihood of angiographically
documented obstructive CAD (Y-axis) is plotted against the
number of traditional risk factors (X-axis) for 264 subjects with
coronary calcium scores below (in front) or above (in back) 170.
(Arad et al. - unpublished observation.)
inordinate number of men and the elderly, while under-
treating women and younger persons.
There is no general consensus at this time regarding these
last two matters. However, a general approach can be
proposed. First, although the GAG score correlates with the
anatomical extent of atherosclerosis and is not a risk factor
per se, it seems logical, on the basis of the data presented
above, to adjust the NGEP-based risk analysis according to
GAG scores. Second, each patient's GAG should be
evaluated with reference to the distribution of GAG in
subjects of the same age and gender." Such an approach
may be used as follows: a GAG score of zero could be
considered as two negative risk factors; and a GAG score
between zero and the 25th percentile for age and gender
may be considered as one negative risk factor. A GAG score
between the 25th and the 50th percentile may be
considered as neutral. A GAG score between the 50th and
the 65th percentile may add one risk factor; a GAG score
between the 65th and the 80th percentile may add two risk
factors; and a GAG score above the 80th percentile for age
and gender may be considered evidence of obstructive
GAD.
It can be concluded that EBGT-derived GAG scores are
currently the best predictors of the presence and extent of
coronary artery disease, and of the likelihood of future
cardiovascular events in both symptomatic and
asymptomatic persons, and that EBGT-derived coronary
artery calcium measurement is therefore the best screening
tool for GAD. Moreover, routine use of EBGT for detection of
GAD can result in substantial health savings. For example,
early detection and treatment with diet or drugs of subjects
with elevated GAG scores will prevent future expenditures
associated with hospitalisation for angina, MI or congestive
heart failure (GHF), as well as those associated with worker's
disability. Gonversely, a very low calcium score in subjects
with isolated hypercholesterolaemia or with relatively few
risk factors is probably a good indication that expensive
cholesterol-lowering medications are not required. Two
preliminary analyses suggest that screening for GAD with
EBGT is cost-effective!9.50 The latter analysis concluded that
using GAG screening to target lipid therapy, rather than
using a cholesterol level of 6.73 mmol/I, would prevent 179%
more events, at the same total cost. A more recent analysis
compared EBGT-derived GAG scores with EGG-based
stress testing, stress thallium, stress echocardiography, and
conventional angiography.51 Using a theoretical model based
on previously published ROG curves for the correlation of
GAG with angiographically measured GAD, the authors
concluded that EBGT is the most cost-effective test for
screening for GAD in high-risk patients, or patients with



































asymptomatic subjects undergoing EBGP8-42 (with follow-up
ranging from 1 to 5 years) and by a follow-up study using
fluoroscopy,'" as well as by a study of subjects with a history
of GAD.""' In addition, EBGT-derived GAG scores predict the
risk of restenosis following angioplasty, with mean pre-
procedure GAG of 92 in patients with subsequent restenosis
versus 228 for patients in whom there was no restenosis.45
As expected, there is a positive correlation between GAG
and other known risk factors for atherosclerosis." It is
therefore essential to compare the predictive value of GAG
with that of other risk factors, and to determine whether
GAG offers an incremental value to any combination of
known risk factors. Spadaro et al. 47 compared the predictive
value of GAG with traditional risk factors in subjects without
a history of MI who presented for first angiography. In
multiple logistic regression analysis incorporating lipid and
traditional non-lipid risk factors, EBGT-derived GAG scores
were the most accurate predictors of the presence of either
any GAD or obstructive GAD. Furthermore, for any number
of risk factors, a GAG score above 170 doubled or tripled
the likelihood of either any GAD or obstructive GAD,
regardless of the number of risk factors (Fig. 4).
The utility of coronary calcification as a screening test for
occult GAD is hampered by the positive correlation between
GAG and age and male gender." EBGT has been criticised
for poor sensitivity (due to universally lower scores) in
women and young males and poor specificity in older
subjects, males in particular (due to the high prevalence of
high scores). In fact, these differences in GAG score
distribution reflect actual differences in plaque burden
between these groups." Nonetheless, the use of raw GAG,
uncorrected for age and gender, may result in treating an
Intravenous contrast coronary
angiography
The value of EBGT is not limited to determination of
coronary calcifications. The most exciting and rapidly
evolVing modality of EBGT is intravenous (IV) contrast EBGT
for imaging of the ventricles, valves and coronary arteries.
New, sophisticated software programs have vastly improved
the applicability of IV contrast EBGT. Studies can be






Fig. 6. EBCT coronary angiography. Intravenous contrast EBCT
coronary angiography can be performed in several minutes and
the images are reconstructed using one of several software
options. (Courtesy of Or John Rumberger, Professor of Medicine,
Mayo Clinic, Rochester, Minn.)
Fig. 5. The cost-effectiveness of EBCT versus other diagnostic
modalities, including stress ECG, stress thallium, stress
echocardiography and coronary angiography. The authors used a
theoretical model to predict cost-effectiveness for subjects with
various pre-test Iikelihoods of CAD, based on previously
published ROC curves. (Reprinted with permission from Springer-
Verlag.")
performed in the cine mode or the single-slice mode. In the
cine mode, 18 images per second are obtained at eight
contiguous levels, with the table stationary, allowing for real-
time assessment of ventricular wall and valve function. Cine
EBCT, which can be presented in four dimensions (3-D in
real time) or reconstructed in any plane of interest, generates
images of superior quality to those obtained with
echocardiography, and produces excellent images of the
right side of the heart. Very precise analyses of myocardial
function, as well as of regional myocardial perfusion by time-
density curves, are now also possible.52•53 Another exciting
new approach involves wall motion analysis before and
during infusion of dipyridamole"" or dobutamine55 to detect
wall motion abnormalities. The high resolution of EBCT for
both the right and the left side of the heart, combined with
the ability to reconstruct the image in any plane as well as in
four dimensions, permits precise evaluation of regional wall
abnormalities.56-58
In addition, in the single-slice mode and with new
software, using shaded surface display, continuous
volumetric (moving slab) reconstruction, or curvilinear space
reconstruction methods, precise imaging and assessment is
achieved. The patency of the proximal and middle portions
of the three major coronary arteries and their branches,59.5O
as well as of bypass grafts'" stents62 and post-angioplasty
vessels,63 can be assessed with accuracies of nearly 90%
for native coronaries and 97% for bypass grafts. Since most
errors are due to technical problems, such as slice gaps,5O it
is expected that with improvement in technique accuracy
will soon approach 100%. Imaging of plaques and
assessment of stenoses and complete obstructions, as well
as stent patency, is rapidly performed in several minutes of
on-line time (Fig. 6). Perspective rendering even allows for
virtual reality, real-time, fly-through imaging of the coronary
arteries.
The ability to analyse coronary and valve anatomy,
regional wall motion abnormalities and myocardial perfusion
Initial dtagoOstic method
-Q- Stress ECG -J- Stress thallum --l:- Stress ecno
~ EBCT CAC -<>-- Angiography
PreveJence of significant CAD in the population in one sitting is unique to EBCT. Comparable complete
evaluation of cardiac function and disease currently requires
a combination of echocardiography, radio-isotope-based
perfusion imaging and angiography, and is much more
expensive and time-consuming. Work-up of chest pain of
unknown aetiology is another example of the versatility of
EBCT. Coronary disease, pulmonary embolism, pericardial
disease and a variety of gastro-intestinal and pulmonary
aetiologies are investigated simultaneously, rather than with
a series of separate tests. Thus, EBCT presents a real
potential for saving in health care.
Some remaining limitations of EBCT include incomplete
visualisation of the distal portions of coronary arteries or
small branches, and artefacts associated with imperfect
breath-holding or beat-to-beat variation in the length of the
cardiac cycle. Despite these limitations, the capacity of
EBCT as a 'one-stop shop' to diagnose coronary disease
already surpasses other available technologies. Expected
improvements in hardware and software capabilities such as
multi-array detectors, increased scanning speed and slice
number which allow for thinner slices and more overlap
between slices, as well as better reconstruction algorithms,
should improve its utility even further.
Other technologies, such as helical CT, MRI and
dichromatic angiography with synchrotron radiation, can
potentially compete with EBCT. Helical CT can assess the
presence of coronary calcifications'" and has also been used
for assessment of bypass graft patency,65 but it is limited by
its slower acquisition time and lack of ECG synchronisation.
No studies with helical CT have reported efficacy in
assessing the degree of bypass graft stenosis or the
evaluation of native coronary arteries. Its slower acquisition
time also limits the usefulness of helical CT for cine studies.
MRI is limited by slower acquisition time and poor spatial
resolution, although recent improvements in techniques
might overcome some of these problems. In addition, MRI
cannot be used for early CAD screening at the present time.
Dichromatic angiography requires a particle accelerator and
is not practical for routine medical use.
EBeT is currently the only technique with proven ability to
perfonm the full spectrum of cardiac diagnoses, inclUding
screening for early atherosclerosis, predicting the risk of
future cardiovascular events, visualising myocardial
anatomy, function and perfusion in real-time and in three
dimensions, and assessing coronary anatomy and
obstruction. Its routine use for the medical evaluation of
cardiac disease will result in more accurate and economical
detection and treatment of heart disease.
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